Zhiren Wang
10PUBLICATIONS
14CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (10)
Sort by Publication Date:
|Aug 21, 2025
A sphingolipid-derived paclitaxel nanovesicle enhances efficacy of combination therapies in triple-negative breast cancer and pancreatic cancer.Zhiren Wang, Wenpan Li, Yanhao Jiang
|Jun 10, 2024
Sphingomyelin-derived epacadostat nanovesicle enhances IDO1 inhibition for improved melanoma combination immunotherapy.Zhiren Wang, Wenpan Li, Jianqin Lu
|Mar 07, 2024
Cholesterol-modified sphingomyelin chimeric lipid bilayer for improved therapeutic delivery.Zhiren Wang, Wenpan Li, Yanhao Jiang
|Nov 09, 2023
Sphingomyelin-derived nanovesicles for the delivery of the IDO1 inhibitor epacadostat enhance metastatic and post-surgical melanoma immunotherapy.Zhiren Wang, Wenpan Li, Yanhao Jiang
|May 30, 2023
Nanotechnology-empowered therapeutics targeting neurodegenerative diseases.Zhiren Wang, Karina Marie Gonzalez, Leyla Estrella Cordova
Pageof 2
Frequent Collaborators
8 joint publications
Jianqin Lu
4 joint publications
Wenpan Li
4 joint publications
Yanhao Jiang
2 joint publications
Leyla Estrella Cordova
2 joint publications
Jennifer Erdrich
1 joint publications
Xingshu Li
1 joint publications
Wei Wang
1 joint publications
Xiaoping Yang
1 joint publications
Jiawei Chen
1 joint publications
Aaron James Scott
